Table 3 Number and prevalence of preoperative findings in candidates for tcMRgFUS.

Gliotic foci

57 (39.0%)

63.3%

0 (0%)

1

Chronic hypoxic-ischemic encephalopathy

27 (18.5%)

30.0%

0 (0%)

1

SWAN hypointense lesion

14 (9.5%)

15.5%

0 (0%)

2

Aracnoidocele

12 (8.2%)

13.3%

0 (0%)

1

Developmental venous anomaly

5 (3.4%)

5.5%

0 (0%)

1

Lacunar infarct

5 (3.4%)

5.5%

0 (0%)

1

Multiple sclerosis lesion (not active)

3 (2.0%)

3.3%

0 (0%)

2

Cavernoma

3 (2.0%)

3.3%

1 (33.3%)

2

Meningioma

2 (1.4%)

2.2%

1 (50.0%)

2

Cavum Vergae

2 (1.4%)

2.2%

2 (100%)

1

Subdural hygroma

2 (1.4%)

2.2%

0 (0%)

1

Pineal Cyst

2 (1.4%)

2.2%

0 (0%)

1

Bone or subcutaneous lesions

2 (1.4%)

1.1%

2 (100%)

2

Multiple sclerosis lesion (active)

1 (0.7%)

1.1%

0 (0%)

2

Subdural hematoma

1 (0.7%)

1.1%

1 (100%)

3

Metallic foreign body (sliver in the frontal subcutaneous tissue)

1 (0.7%)

1.1%

1 (100%)

2

Asymmetry of the lateral ventricles

1 (0.7%)

1.1%

1 (100%)

1

Basilar artery vascular ectasia

1 (0.7%)

1.1%

0 (0%)

1

Cavum septum pellucidum

1 (0.7%)

1.1%

1 (100%)

1

Choroidal fissure cysts

1 (0.7%)

1.1%

0 (0%)

1

Mega cisterna magna

1 (0.7%)

1.1%

0 (0%)

1

Acoustic schwannoma

1 (0.7%)

1.1%

0 (0%)

1

Temporal bone lesion (petrous apicitis)

1 (0.7%)

1.1%

1 (100%)

1